Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
USA115th CongressHR-2410| House
| Updated: 2/27/2018
Danny K. Davis
Democratic Representative
Illinois
Health, Education, Labor, and Pensions Committee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
(This measure has not been amended since it was introduced. The expanded summary of the House reported version is repeated here.) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (Sec. 2) This bill amends the Public Health Service Act to authorize the Department of Health and Human Services to make grants to states to: (1) collect data on the prevalence and distribution of sickle cell disease, (2) conduct sickle cell disease public health initiatives to improve access to care and health outcomes, and (3) identify and evaluate strategies for prevention and treatment of sickle cell disease complications. (Sec. 4) The demonstration program to improve the prevention and treatment of sickle cell disease is revised, reauthorized through FY2022, and moved from the American Jobs Creation Act of 2004 to the Public Health Service Act.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Subcommittee Consideration and Mark-up Session Held.
Forwarded by Subcommittee to Full Committee by Voice Vote .
Ordered to be Reported by Voice Vote.
Committee Consideration and Mark-up Session Held.
Placed on the Union Calendar, Calendar No. 258.
Reported by the Committee on Energy and Commerce. H. Rept. 115-354.
Mr. Burgess moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H1240-1243)
DEBATE - The House proceeded with forty minutes of debate on H.R. 2410.
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H1240-1241)
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H1240-1241)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health
Blood and blood diseasesHealth care coverage and accessHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsMinority healthResearch administration and funding
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017
USA115th CongressHR-2410| House
| Updated: 2/27/2018
(This measure has not been amended since it was introduced. The expanded summary of the House reported version is repeated here.) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 (Sec. 2) This bill amends the Public Health Service Act to authorize the Department of Health and Human Services to make grants to states to: (1) collect data on the prevalence and distribution of sickle cell disease, (2) conduct sickle cell disease public health initiatives to improve access to care and health outcomes, and (3) identify and evaluate strategies for prevention and treatment of sickle cell disease complications. (Sec. 4) The demonstration program to improve the prevention and treatment of sickle cell disease is revised, reauthorized through FY2022, and moved from the American Jobs Creation Act of 2004 to the Public Health Service Act.
Suggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
Subcommittee Consideration and Mark-up Session Held.
Forwarded by Subcommittee to Full Committee by Voice Vote .
Ordered to be Reported by Voice Vote.
Committee Consideration and Mark-up Session Held.
Placed on the Union Calendar, Calendar No. 258.
Reported by the Committee on Energy and Commerce. H. Rept. 115-354.
Mr. Burgess moved to suspend the rules and pass the bill.
Considered under suspension of the rules. (consideration: CR H1240-1243)
DEBATE - The House proceeded with forty minutes of debate on H.R. 2410.
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H1240-1241)
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H1240-1241)
Motion to reconsider laid on the table Agreed to without objection.
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Danny K. Davis
Democratic Representative
Illinois
Health, Education, Labor, and Pensions Committee, Health Subcommittee, Energy and Commerce Committee
Health
Related Bills
- S 115-3660: A bill to improve the health of minority individuals, and for other purposes.
- HR 115-5942: To improve the health of minority individuals, and for other purposes.
- S 115-2465: Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Blood and blood diseasesHealth care coverage and accessHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careMedical researchMedical tests and diagnostic methodsMinority healthResearch administration and funding